EUVIMEDEUVIMED entdecken
Crossref

Transcriptional expression of SLC16A7 as a biomarker of occult lymph node metastases in patients with head and neck squamous cell carcinoma

Mercedes Camacho, Cristina Vázquez-López, Cristina Valero, Anna Holgado, Ximena Terra, Francesc Xavier Avilés-Jurado, Xavier León

European Archives of Oto-Rhino-Laryngology · 2024

DOI: 10.1007/s00405-024-08882-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Archives of Oto-Rhino-Laryngology, 2024. Verfasst von Mercedes Camacho und 6 weiteren Autor:innen. Beteiligte Einrichtung: Genomics of Complex Diseases. Institut de Recerca, IIB Sant Pau, Barcelona, Spain. Hauptthemen laut MEDLINE: Lymphatic Metastasis, Head and Neck Neoplasms, Biomarkers, Tumor, Squamous Cell Carcinoma of Head and Neck. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: Instituto de Salud Carlos III, Fundación Científica Asociación Española Contra el Cáncer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Glucose is the main energy substrate of tumor cells. This study aims to assess whether the transcriptional expression of glucose metabolism-related genes is associated with occult lymph node metastases in head and neck squamous cell carcinoma (HNSCC) patients. METHODS: We examined the transcriptional expression of a panel of glucose metabolism-related genes in a cohort of 53 patients with HNSCC without cervical lymph node involvement at the time of diagnosis (cN0) and subsequently treated with elective neck dissection. RESULTS: Occult lymph node metastases were found in 37.7% (n = 20) of the patients. Among the analyzed genes, SLC16A7 exhibited the strongest association with the presence of occult lymph node metastases. Patients with occult lymph node metastases (cN0/pN +) had significantly lower SLC16A7 expression values (p = 0.001). Patients with low SLC16A7 expression (n = 17, 32.1%) had a frequency of occult lymph node metastases of 76.5%, while for patients with high SLCA16A7 expression (n = 36, 67.9%) it was 19.4% (P = 0.0001). A multivariable analysis showed that patients with low expression of SLC16A7 had a 12.6 times higher risk of developing occult lymph node metastases. CONCLUSION: cN0 HNSCC patients with low SLC16A7 expression had a higher risk of occult lymph node metastases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphatic MetastasisHead and Neck NeoplasmsBiomarkers, TumorSquamous Cell Carcinoma of Head and NeckMonocarboxylic Acid TransportersHumansMaleFemaleMiddle AgedAgedNeck DissectionAdultCarcinoma, Squamous CellLymph NodesAged, 80 and overRetrospective StudiesGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

BiomarkersHead and neck squamous cell carcinomaMCT2Occult lymph node metastasesSLCA16A7

Substanzen

Biomarkers, TumorMonocarboxylic Acid Transporters

Autor:innen und Institutionen

  • Genomics of Complex Diseases. Institut de Recerca, IIB Sant Pau, Barcelona, Spain.
  • Otorhinolaryngology Head-Neck Surgery Department, Hospital de La Santa Creu I Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain. cvazquezl@santpau.cat.
  • Otorhinolaryngology Head-Neck Surgery Department, Hospital de La Santa Creu I Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • MoBioFood Research Group, Department of Biochemistry and Biotechnology, Universitat Rovira I Virgili, Tarragona, Spain.
  • Otorhinolaryngology Head-Neck Surgery Department. Hospital Clínic de Barcelona. IDIBAPS Universitat de Barcelona, Barcelona, Spain.
  • Center On Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid, Spain.

Förderung

  • Instituto de Salud Carlos III
  • Fundación Científica Asociación Española Contra el Cáncer

Zitieren

APA

Camacho, M., Vázquez-López, C., Valero, C., Holgado, A., Terra, X., Avilés-Jurado, F. X., & León, X. (2024). Transcriptional expression of SLC16A7 as a biomarker of occult lymph node metastases in patients with head and neck squamous cell carcinoma. European Archives of Oto-Rhino-Laryngology. https://doi.org/10.1007/s00405-024-08882-9

Vancouver

Camacho M, Vázquez-López C, Valero C, Holgado A, Terra X, Avilés-Jurado FX, et al. Transcriptional expression of SLC16A7 as a biomarker of occult lymph node metastases in patients with head and neck squamous cell carcinoma. European Archives of Oto-Rhino-Laryngology. 2024. doi:10.1007/s00405-024-08882-9

BibTeX
@article{Camacho2024,
  author = {Camacho, Mercedes and Vázquez-López, Cristina and Valero, Cristina and Holgado, Anna and Terra, Ximena and Avilés-Jurado, Francesc Xavier and León, Xavier},
  title = {Transcriptional expression of SLC16A7 as a biomarker of occult lymph node metastases in patients with head and neck squamous cell carcinoma},
  journal = {European Archives of Oto-Rhino-Laryngology},
  year = {2024},
  doi = {10.1007/s00405-024-08882-9}
}
Kostenlos starten →